Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05412381 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PRP in ACLR to Prevent PTOA

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v6
  2. Phase: Phase 4 to Phase 3
    • Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025
    • Site contact updated
    v5
  3. 2 versions Re-verified since Jul 31, 2023, no change to tracked fieldsv3-v4
  4. Start date changed from estimate of Jun 15, 2022 to Jun 27, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of our study is to examine the effect of platelet-rich-plasma (PRP) injection on the short-term resolution of post-injury inflammation (biomarkers) and improvement in joint function in patients with acute ACL injury. This RCT has been powered based on the questionnaire KOOS Jr. but it is considered a 'pilot study' in terms of the lab analysis proposed.
Trial Details
NCT Number NCT05412381
Lead Sponsor Hospital for Special Surgery, New York
Collaborators: Orthopedic Research and Education Foundation
Conditions
(from sponsor)		 Anterior Cruciate Ligament Injuries, Post-traumatic Osteoarthritis, PRP
Related terms Anterior Cruciate Ligament Injuries
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov